Zobrazeno 1 - 10
of 66
pro vyhledávání: '"HIRAKATA, Hitoshi"'
Autor:
Kawata, Nozomu, Nagane, Yusuke, Hirakata, Hitoshi, Ichinose, Taketo, Okada, Yasuhiro, Yamaguchi, Kenya, Takahashi, Satoru
Publikováno v:
In Urology 2007 69(6):1049-1053
Autor:
Kawata, Nozomu, Nagane, Yusuke, Igarashi, Takumi, Hirakata, Hitoshi, Ichinose, Taketo, Hachiya, Takahiko, Takimoto, Yukie, Takahashi, Satoru
Publikováno v:
In Urology 2006 68(3):523-527
Autor:
Kawata, Nozomu, Yamaguchi, Kenya, Hirakata, Hitoshi, Hachiya, Takahiko, Yoshida, Toshio, Takimoto, Yukie
Publikováno v:
In Urology 2005 66(4):736-740
Autor:
Kawata, Nozomu1, Hirakata, Hitoshi1, Yuge, Humikazu1, Kodama, Masahito1, Sugimoto, Shuji1, Yagasaki, Hiroki1, Mochida, Junichi1, Fujimura, Kei1, Takimoto, Yukie1
Publikováno v:
International Journal of Urology. Oct2000, Vol. 7 Issue 10, p382-385. 4p.
Autor:
Kawata, Nozomu, Ichinose, Takeo, Hachiya, Takahiko, Hirakata, Hitoshi, Igarashi, Takumi, Nagane, Yusuke, Morita, Koutaro, Takimoto, Yukie
Publikováno v:
泌尿器科紀要. 52(8):603-608
This study examined the outcome of postoperative recurrence therapy on renal cell carcinoma (RCC) prevention involving treatment with single doses of interferon-gamma (IFN-gamma). From 1990-2000, 37 patients with no distant metastasis at the time the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::7226589acc2ce1651949b4c8d610fa93
http://hdl.handle.net/2433/71213
http://hdl.handle.net/2433/71213
Autor:
Kawata, Nozomu, Yagasaki, Hiroki, Hirakata, Hitoshi, Sugimoto, Shuji, Igarashi, Takumi, Nagane, Yusuke, Morita, Koutaro, Takimoto, Yukie
Publikováno v:
泌尿器科紀要. 50(3):157-163
著者らの施設において腎細胞癌の診断で腎摘除を行った148例中32例を対象に, 進行性腎細胞癌における血管新生因子, および治療に奏功した症例と進行した症例の相違について検討した.そ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::10b40b537558d49b322f31edddbe5ca9
http://hdl.handle.net/2433/113337
http://hdl.handle.net/2433/113337
Autor:
YUGE, Fumikazu, HIRAKATA, Hitoshi, IGARASHI, Hiroshi, KODAMA, Masahito, KAWATA, Nozomu, TAKIMOTO, Yukie
Publikováno v:
泌尿器科紀要. 45(7):453-456
1)膀胱癌組織28例を用いて検討した. 2)Ki-67のLIは組織学的異形度, 深達度と相関した. 3)p53, Ki-67のLIに相関性を認めた.しかし, 初発表在性で再発を繰り返し, 浸潤性に移行した症例の中に両
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::145ce3bec5ba3bd930c98c806dc66865
http://hdl.handle.net/2433/114087
http://hdl.handle.net/2433/114087
Autor:
KAWATA, Nozomu, HIRAKATA, Hitoshi, IGARASHI, Takumi, MINEI, Sadatsugu, HAMANO, Kiminari, KODAMA, Masahito, YAMAMOTO, Tadao, TAKIMOTO, Yukie
Publikováno v:
泌尿器科紀要. 42(7):509-512
1)53歳女.IFN-γの皮下投与, 吸入療法が無効であった腎細胞癌の肺転移症例に対して, IFN-αとγの併用持続皮下注を行いCRが得られた.この治療方法は肺転移病巣に対して有効な治療方法の一
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::8b7858bef7e9c4732729a835d2d50f9c
http://hdl.handle.net/2433/115768
http://hdl.handle.net/2433/115768
Autor:
KAWATA, Nozomu, TAKIMOTO, Yukie, HIRANO, Daisaku, YAMAMOTO, Tadao, HIRAKATA, Hitoshi, YAMANAKA, Yataro, OKADA, Yasuhiro, CHINO, Kenji, SUGIMOTO, Shuji, IGARASHI, Takumi
Publikováno v:
泌尿器科紀要. 42(1):1-4
1)腎細胞癌例を対象として, 術前にIFN-γを投与した投与群と無投与群で比べると, 投与群でCD3, CD8, CD11b, ICAM-1が有意に多く認められた. 2)High stageの例で無投与群に比べ, CD3, CD8, CD11b, ICAM-1が
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::68e69075daa144f038df754801d504bd
http://hdl.handle.net/2433/115661
http://hdl.handle.net/2433/115661
Autor:
Kawata, Nozomu, Ono, Masaya, Kodama, Masahito, Yamanaka, Yataro, Hirakata, Hitoshi, Hirano, Daisaku, Fuse, Takuro, Takimoto, Yukie
Publikováno v:
泌尿器科紀要. 41(1):21-26
1)術後IFN-γの周期的投与(B法)を1年間再発転移予防目的で行い, ADCC活性は投与2週後に上昇し, NK活性は6ヵ月後に上昇する傾向にあり, 1年後まで持続した。2)有意ではないが, 持続的投与法(A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::d9c4fb65709108889dd5c41510be1944
http://hdl.handle.net/2433/115434
http://hdl.handle.net/2433/115434